Fetal Encephalopathy
Fetal Encephalopathy - Related Videos
08:47
The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
0 Views •
Cited by 48 •
2008
The postnatal rat model for hypoxic-ischemic brain injury is a well-established model of human neonatal hypoxic ischemic encephalopathy (HIE). In this article, we describe the model of HIE in post-natal rat pups.
10:15
A Novel Method to Model Chronic Traumatic Encephalopathy in Drosophila
0 Views •
Cited by 19 •
2017
Here, we describe a new approach to inflict closed-head traumatic brain injury in Drosophila melanogaster. Our method has the advantage of directly delivering repetitive impacts with adjustable strength to the head alone. Further exploration of the invertebrate system will help to illuminate the pathogenesis of chronic traumatic encephalopathy.
03:36
Inducing Hypoxic-Ischemic and Inflammatory Conditions to Model Encephalopathy in Prenatal Rats
0 Views •
2025
Source: Jantzie, L. L., et. al. Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats. J. Vis. Exp. (2015)This video demonstrates a protocol to induce hypoxic-ischemic and inflammatory conditions in fetal rats by restricting uterine blood flow and injecting LPS, modeling neuroinflammation and disrupted brain development relevant to preterm birth studies.
10:30
A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy
0 Views •
Cited by 37 •
2015
Hypoxic-ischemic encephalopathy following perinatal asphyxia can be studied using animal models. We demonstrate the procedures necessary for establishing a piglet model of neonatal hypoxic-ischemic encephalopathy.
01:29
Hepatic Encephalopathy
0 Views •
2026
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
FAQs
When oxygen or blood delivery falls, fetal brain cells cannot sustain oxidative metabolism, so ATP production declines. This energy deficit disrupts cellular function and can promote excitotoxicity, oxidative stress, and neuronal cell death. The sequence helps explain why impaired fetal circulation is studied as a mechanism of brain injury and why early recognition may influence perinatal care.
Not all cases follow an oxygen-deprivation pathway. Infection and inflammation can alter the developing nervous system, while genetic conditions and metabolic disturbances provide different biological routes to dysfunction. Distinguishing these contributors matters because fetal encephalopathy represents varied mechanisms rather than one uniform disease process, shaping which biomarkers or investigations may be most informative.
Once oxidative metabolism is impaired, reduced ATP can be followed by excitotoxicity and oxidative stress, with neuronal cell death as a possible endpoint. Studying these linked events allows neuroscience researchers to examine how an early metabolic disturbance becomes structural or functional injury. That connection is relevant to understanding potential effects on survival and later neurodevelopment.
Fetal imaging provides a way to investigate brain development before birth and to relate observed developmental patterns to possible neurological dysfunction. In the broader assessment process, imaging is interpreted with prenatal monitoring and molecular or clinical biomarkers. This combined context supports earlier risk assessment and helps researchers study how prenatal disturbances may affect later neurodevelopment.
Prenatal monitoring supports earlier assessment of risk to the developing brain and can contribute to decisions about targeted perinatal care. In research, monitoring information can be considered alongside fetal imaging and biomarkers to investigate how neurological dysfunction develops before birth. This approach connects observations during pregnancy with potential consequences for survival and later neurodevelopment.
Molecular and clinical biomarkers offer complementary perspectives on fetal encephalopathy. Molecular biomarkers can help investigate biological processes, while clinical biomarkers can connect those processes with clinically observed risk. Their use supports investigation of varied contributors, including impaired oxygen or blood delivery, infection, inflammation, genetic conditions, and metabolic disturbances, and may aid earlier risk assessment.
Neuroscience research links prenatal observations with cellular events that may damage the developing brain. By examining impaired oxidative metabolism, ATP loss, excitotoxicity, oxidative stress, and neuronal cell death alongside clinical findings, investigators can identify pathways relevant to risk assessment and targeted perinatal care. This work also supports research into strategies intended to protect the developing brain.